Kingfa Science & Technology (India) Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: March 6, 2026, 2:42 am

Market Cap	5,625 Cr.
Current Price	4,151
Intrinsic Value	₹8,417.63
High / Low	4,987/2,451
Stock P/E	33.5
Book Value	955
Dividend Yield	0.00 %
ROCE	30.6 %
ROE	23.2 %
Face Value	10.0
PEG Ratio	0.86

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Kingfa Science & Technology (India) Ltd

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Kingfa Science & Technology (India) Ltd	5,625 Cr.	4,151	4,987/2,451	33.5	955	0.00 %	30.6 %	23.2 %	10.0
Responsive Industries Ltd	4,543 Cr.	170	251/156	25.2	55.2	0.06 %	15.8 %	16.0 %	1.00
DDev Plastiks Industries Ltd	2,734 Cr.	264	360/213	13.7	88.5	0.66 %	33.9 %	24.9 %	1.00
Mold-Tek Packaging Ltd	1,881 Cr.	566	893/410	27.7	201	0.71 %	12.4 %	9.81 %	5.00
Dhunseri Ventures Ltd	795 Cr.	227	402/220		923	2.21 %	6.55 %	4.69 %	10.0
Industry Average	1,461.17 Cr	422.54		46.04	183.16	0.38%	16.30%	12.17%	8.25

All Competitor Stocks of Kingfa Science & Technology (India) Ltd

Quarterly Result

Metric	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	340	366	339	351	394	404	416	418	440	470	462	466	489
Expenses	310	311	289	306	356	354	359	362	389	409	404	405	428
Operating Profit	31	55	50	45	38	51	57	56	51	60	58	61	62
OPM %	9%	15%	15%	13%	10%	13%	14%	13%	12%	13%	13%	13%	13%
Other Income	1	1	2	0	1	2	2	1	5	2	4	3	7
Interest	1	2	1	1	1	2	1	1	1	2	1	1	1
Depreciation	4	4	4	4	5	5	5	5	5	6	6	7	7
Profit before tax	27	49	47	40	32	45	52	50	49	54	54	55	61
Tax %	25%	26%	25%	25%	25%	26%	25%	26%	30%	23%	26%	26%	26%
Net Profit	20	37	35	30	24	34	39	37	35	42	40	41	45
EPS in Rs	16.70	30.24	28.93	24.44	20.09	27.70	32.26	30.77	28.60	34.60	32.86	30.36	33.33

Last Updated: March 4, 2026, 4:16 am

Below is a detailed analysis of the quarterly data for Kingfa Science & Technology (India) Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:

For Sales, as of Dec 2025, the value is 489.00 Cr.. The value appears strong and on an upward trend. It has increased from 466.00 Cr. (Sep 2025) to 489.00 Cr., marking an increase of 23.00 Cr..
For Expenses, as of Dec 2025, the value is 428.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 405.00 Cr. (Sep 2025) to 428.00 Cr., marking an increase of 23.00 Cr..
For Operating Profit, as of Dec 2025, the value is 62.00 Cr.. The value appears strong and on an upward trend. It has increased from 61.00 Cr. (Sep 2025) to 62.00 Cr., marking an increase of 1.00 Cr..
For OPM %, as of Dec 2025, the value is 13.00%. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 13.00%.
For Other Income, as of Dec 2025, the value is 7.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Sep 2025) to 7.00 Cr., marking an increase of 4.00 Cr..
For Interest, as of Dec 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 1.00 Cr..
For Depreciation, as of Dec 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 7.00 Cr..
For Profit before tax, as of Dec 2025, the value is 61.00 Cr.. The value appears strong and on an upward trend. It has increased from 55.00 Cr. (Sep 2025) to 61.00 Cr., marking an increase of 6.00 Cr..
For Tax %, as of Dec 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 26.00%.
For Net Profit, as of Dec 2025, the value is 45.00 Cr.. The value appears strong and on an upward trend. It has increased from 41.00 Cr. (Sep 2025) to 45.00 Cr., marking an increase of 4.00 Cr..
For EPS in Rs, as of Dec 2025, the value is 33.33. The value appears strong and on an upward trend. It has increased from 30.36 (Sep 2025) to 33.33, marking an increase of 2.97.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 24, 2026, 6:46 pm

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	178	219	314	427	602	702	742	627	1,048	1,404	1,488	1,745	1,887
Expenses	181	212	288	408	560	666	698	607	966	1,276	1,303	1,520	1,646
Operating Profit	-3	6	27	19	41	35	43	20	82	128	185	225	241
OPM %	-2%	3%	8%	5%	7%	5%	6%	3%	8%	9%	12%	13%	13%
Other Income	0	0	1	4	6	4	3	6	-22	2	3	9	15
Interest	7	8	7	2	2	2	4	3	5	7	6	7	5
Depreciation	3	3	3	3	6	8	9	11	13	14	18	22	26
Profit before tax	-12	-5	17	18	39	29	33	12	41	110	164	206	224
Tax %	-31%	-35%	38%	30%	36%	35%	26%	55%	26%	26%	25%	26%
Net Profit	-8	-3	11	12	25	19	25	5	31	81	123	153	168
EPS in Rs	-6.95	-2.49	8.93	10.24	20.35	15.74	20.33	4.39	25.29	67.22	101.17	126.22	131.15
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	10%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	62.50%	466.67%	9.09%	108.33%	-24.00%	31.58%	-80.00%	520.00%	161.29%	51.85%	24.39%
Change in YoY Net Profit Growth (%)	0.00%	404.17%	-457.58%	99.24%	-132.33%	55.58%	-111.58%	600.00%	-358.71%	-109.44%	-27.46%

Kingfa Science & Technology (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	23%
5 Years:	19%
3 Years:	19%
TTM:	14%

Compounded Profit Growth
10 Years:	48%
5 Years:	44%
3 Years:	48%
TTM:	21%

Stock Price CAGR
10 Years:	32%
5 Years:	56%
3 Years:	51%
1 Year:	29%

Return on Equity
10 Years:	14%
5 Years:	18%
3 Years:	22%
Last Year:	23%

Last Updated: September 5, 2025, 9:05 am

Balance Sheet

Last Updated: December 4, 2025, 1:32 am

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	6	6	10	10	12	12	12	12	12	12	12	12	14
Reserves	5	2	109	234	293	312	336	342	372	454	576	716	1,281
Borrowings	62	75	16	42	21	17	46	71	46	42	33	43	19
Other Liabilities	31	41	95	119	159	210	202	246	449	502	373	384	421
Total Liabilities	105	125	230	405	485	551	596	671	880	1,010	994	1,156	1,735
Fixed Assets	24	25	29	76	88	85	107	129	126	123	252	244	290
CWIP	0	1	41	10	2	79	115	123	127	131	2	41	45
Investments	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	81	99	160	319	395	388	375	419	627	756	740	871	1,399
Total Assets	105	125	230	405	485	551	596	671	880	1,010	994	1,156	1,735

Below is a detailed analysis of the balance sheet data for Kingfa Science & Technology (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

For Equity Capital, as of Sep 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Mar 2025) to 14.00 Cr., marking an increase of 2.00 Cr..
For Reserves, as of Sep 2025, the value is 1,281.00 Cr.. The value appears strong and on an upward trend. It has increased from 716.00 Cr. (Mar 2025) to 1,281.00 Cr., marking an increase of 565.00 Cr..
For Borrowings, as of Sep 2025, the value is 19.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 43.00 Cr. (Mar 2025) to 19.00 Cr., marking a decrease of 24.00 Cr..
For Other Liabilities, as of Sep 2025, the value is 421.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 384.00 Cr. (Mar 2025) to 421.00 Cr., marking an increase of 37.00 Cr..
For Total Liabilities, as of Sep 2025, the value is 1,735.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,156.00 Cr. (Mar 2025) to 1,735.00 Cr., marking an increase of 579.00 Cr..
For Fixed Assets, as of Sep 2025, the value is 290.00 Cr.. The value appears strong and on an upward trend. It has increased from 244.00 Cr. (Mar 2025) to 290.00 Cr., marking an increase of 46.00 Cr..
For CWIP, as of Sep 2025, the value is 45.00 Cr.. The value appears strong and on an upward trend. It has increased from 41.00 Cr. (Mar 2025) to 45.00 Cr., marking an increase of 4.00 Cr..
For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
For Other Assets, as of Sep 2025, the value is 1,399.00 Cr.. The value appears strong and on an upward trend. It has increased from 871.00 Cr. (Mar 2025) to 1,399.00 Cr., marking an increase of 528.00 Cr..
For Total Assets, as of Sep 2025, the value is 1,735.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,156.00 Cr. (Mar 2025) to 1,735.00 Cr., marking an increase of 579.00 Cr..

Notably, the Reserves (1,281.00 Cr.) exceed the Borrowings (19.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	-24	-1	19	-119	-116	96	30	-2	38	27	16	60
Cash from Investing Activity +	-1	-4	-47	-18	-6	-77	-63	-14	-19	-12	2	-30
Cash from Financing Activity +	25	5	34	137	14	-7	22	17	-14	-21	-8	-7
Net Cash Flow	0	0	6	-1	-108	12	-11	1	5	-6	10	23

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	-65.00	-69.00	11.00	-23.00	20.00	18.00	-3.00	-51.00	36.00	86.00	152.00	182.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	97	93	99	111	110	109	97	123	99	93	99	93
Inventory Days	54	64	85	69	85	63	67	100	110	94	76	82
Days Payable	66	72	127	108	108	119	115	152	181	155	110	94
Cash Conversion Cycle	85	85	57	72	86	53	49	71	28	32	66	80
Working Capital Days	-7	-14	66	59	96	59	55	57	39	45	78	85
ROCE %	-9%	4%	22%	9%	13%	9%	10%	4%	16%	25%	30%	31%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	67.02%	67.02%
FIIs	6.33%	6.34%	6.35%	6.36%	6.33%	6.34%	6.35%	6.35%	6.35%	6.34%	7.78%	7.74%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.04%	0.00%	0.17%	0.15%	8.75%	8.75%
Public	18.67%	18.66%	18.66%	18.64%	18.67%	18.67%	18.61%	18.65%	18.47%	18.51%	16.45%	16.50%
No. of Shareholders	7,975	8,490	9,419	9,266	9,452	9,414	10,566	12,200	12,158	12,636	12,610	12,303

Shareholding Pattern Chart

No. of Shareholders

Kingfa Science & Technology (India) Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
SBI Conservative Hybrid Fund	357,348	1.54	151.7	N/A	N/A	N/A
SBI Flexicap Fund	345,821	0.64	148.1	N/A	N/A	N/A
SBI Automotive Opportunities Fund	200,000	1.72	85.78	184,438	2026-02-22 01:23:36	8.44%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	126.22	101.17	67.22	25.29	4.39
Diluted EPS (Rs.)	126.22	101.17	67.22	25.29	4.39
Cash EPS (Rs.)	144.15	116.35	78.90	36.00	13.31
Book Value[Excl.RevalReserv]/Share (Rs.)	601.63	486.00	384.78	317.57	292.29
Book Value[Incl.RevalReserv]/Share (Rs.)	601.63	486.00	384.78	317.57	292.29
Dividend / Share (Rs.)	10.00	10.00	0.00	0.00	0.00
Revenue From Operations / Share (Rs.)	1440.64	1228.45	1159.08	865.13	517.93
PBDIT / Share (Rs.)	193.59	155.39	107.56	68.41	21.43
PBIT / Share (Rs.)	175.66	140.21	95.89	57.70	12.52
PBT / Share (Rs.)	170.16	135.58	90.49	34.14	9.79
Net Profit / Share (Rs.)	126.22	101.17	67.22	25.29	4.39
PBDIT Margin (%)	13.43	12.64	9.27	7.90	4.13
PBIT Margin (%)	12.19	11.41	8.27	6.66	2.41
PBT Margin (%)	11.81	11.03	7.80	3.94	1.88
Net Profit Margin (%)	8.76	8.23	5.79	2.92	0.84
Return on Networth / Equity (%)	20.97	20.81	17.47	7.96	1.50
Return on Capital Employeed (%)	29.00	28.66	24.65	17.08	3.92
Return On Assets (%)	13.22	12.32	8.05	3.49	0.79
Long Term Debt / Equity (X)	0.00	0.00	0.00	0.04	0.06
Total Debt / Equity (X)	0.05	0.05	0.08	0.10	0.11
Asset Turnover Ratio (%)	1.62	1.48	1.49	1.35	0.98
Current Ratio (X)	2.02	1.80	1.37	1.30	1.45
Quick Ratio (X)	1.31	1.20	0.83	0.74	0.94
Inventory Turnover Ratio (X)	6.42	4.11	3.84	4.47	4.03
Dividend Payout Ratio (NP) (%)	7.92	0.00	0.00	0.00	0.00
Dividend Payout Ratio (CP) (%)	6.93	0.00	0.00	0.00	0.00
Earning Retention Ratio (%)	92.08	0.00	0.00	0.00	0.00
Cash Earning Retention Ratio (%)	93.07	0.00	0.00	0.00	0.00
Interest Coverage Ratio (X)	35.23	33.55	19.95	15.67	7.84
Interest Coverage Ratio (Post Tax) (X)	23.97	22.84	13.47	11.19	2.61
Enterprise Value (Cr.)	3600.92	2398.91	1621.01	1546.18	724.65
EV / Net Operating Revenue (X)	2.06	1.61	1.15	1.48	1.16
EV / EBITDA (X)	15.36	12.75	12.44	18.66	27.92
MarketCap / Net Operating Revenue (X)	2.06	1.60	1.14	1.46	1.13
Retention Ratios (%)	92.07	0.00	0.00	0.00	0.00
Price / BV (X)	4.92	4.03	3.45	3.99	2.00
Price / Net Operating Revenue (X)	2.06	1.60	1.14	1.46	1.13
EarningsYield	0.04	0.05	0.05	0.01	0.01

After reviewing the key financial ratios for Kingfa Science & Technology (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 25, the value is 126.22. This value is within the healthy range. It has increased from 101.17 (Mar 24) to 126.22, marking an increase of 25.05.
For Diluted EPS (Rs.), as of Mar 25, the value is 126.22. This value is within the healthy range. It has increased from 101.17 (Mar 24) to 126.22, marking an increase of 25.05.
For Cash EPS (Rs.), as of Mar 25, the value is 144.15. This value is within the healthy range. It has increased from 116.35 (Mar 24) to 144.15, marking an increase of 27.80.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 601.63. It has increased from 486.00 (Mar 24) to 601.63, marking an increase of 115.63.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 601.63. It has increased from 486.00 (Mar 24) to 601.63, marking an increase of 115.63.
For Dividend / Share (Rs.), as of Mar 25, the value is 10.00. This value exceeds the healthy maximum of 3. There is no change compared to the previous period (Mar 24) which recorded 10.00.
For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,440.64. It has increased from 1,228.45 (Mar 24) to 1,440.64, marking an increase of 212.19.
For PBDIT / Share (Rs.), as of Mar 25, the value is 193.59. This value is within the healthy range. It has increased from 155.39 (Mar 24) to 193.59, marking an increase of 38.20.
For PBIT / Share (Rs.), as of Mar 25, the value is 175.66. This value is within the healthy range. It has increased from 140.21 (Mar 24) to 175.66, marking an increase of 35.45.
For PBT / Share (Rs.), as of Mar 25, the value is 170.16. This value is within the healthy range. It has increased from 135.58 (Mar 24) to 170.16, marking an increase of 34.58.
For Net Profit / Share (Rs.), as of Mar 25, the value is 126.22. This value is within the healthy range. It has increased from 101.17 (Mar 24) to 126.22, marking an increase of 25.05.
For PBDIT Margin (%), as of Mar 25, the value is 13.43. This value is within the healthy range. It has increased from 12.64 (Mar 24) to 13.43, marking an increase of 0.79.
For PBIT Margin (%), as of Mar 25, the value is 12.19. This value is within the healthy range. It has increased from 11.41 (Mar 24) to 12.19, marking an increase of 0.78.
For PBT Margin (%), as of Mar 25, the value is 11.81. This value is within the healthy range. It has increased from 11.03 (Mar 24) to 11.81, marking an increase of 0.78.
For Net Profit Margin (%), as of Mar 25, the value is 8.76. This value is within the healthy range. It has increased from 8.23 (Mar 24) to 8.76, marking an increase of 0.53.
For Return on Networth / Equity (%), as of Mar 25, the value is 20.97. This value is within the healthy range. It has increased from 20.81 (Mar 24) to 20.97, marking an increase of 0.16.
For Return on Capital Employeed (%), as of Mar 25, the value is 29.00. This value is within the healthy range. It has increased from 28.66 (Mar 24) to 29.00, marking an increase of 0.34.
For Return On Assets (%), as of Mar 25, the value is 13.22. This value is within the healthy range. It has increased from 12.32 (Mar 24) to 13.22, marking an increase of 0.90.
For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
For Total Debt / Equity (X), as of Mar 25, the value is 0.05. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.05.
For Asset Turnover Ratio (%), as of Mar 25, the value is 1.62. It has increased from 1.48 (Mar 24) to 1.62, marking an increase of 0.14.
For Current Ratio (X), as of Mar 25, the value is 2.02. This value is within the healthy range. It has increased from 1.80 (Mar 24) to 2.02, marking an increase of 0.22.
For Quick Ratio (X), as of Mar 25, the value is 1.31. This value is within the healthy range. It has increased from 1.20 (Mar 24) to 1.31, marking an increase of 0.11.
For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.42. This value is within the healthy range. It has increased from 4.11 (Mar 24) to 6.42, marking an increase of 2.31.
For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 7.92. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 7.92, marking an increase of 7.92.
For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 6.93. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 6.93, marking an increase of 6.93.
For Earning Retention Ratio (%), as of Mar 25, the value is 92.08. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 92.08, marking an increase of 92.08.
For Cash Earning Retention Ratio (%), as of Mar 25, the value is 93.07. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 93.07, marking an increase of 93.07.
For Interest Coverage Ratio (X), as of Mar 25, the value is 35.23. This value is within the healthy range. It has increased from 33.55 (Mar 24) to 35.23, marking an increase of 1.68.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 23.97. This value is within the healthy range. It has increased from 22.84 (Mar 24) to 23.97, marking an increase of 1.13.
For Enterprise Value (Cr.), as of Mar 25, the value is 3,600.92. It has increased from 2,398.91 (Mar 24) to 3,600.92, marking an increase of 1,202.01.
For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.06. This value is within the healthy range. It has increased from 1.61 (Mar 24) to 2.06, marking an increase of 0.45.
For EV / EBITDA (X), as of Mar 25, the value is 15.36. This value exceeds the healthy maximum of 15. It has increased from 12.75 (Mar 24) to 15.36, marking an increase of 2.61.
For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.06. This value is within the healthy range. It has increased from 1.60 (Mar 24) to 2.06, marking an increase of 0.46.
For Retention Ratios (%), as of Mar 25, the value is 92.07. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 92.07, marking an increase of 92.07.
For Price / BV (X), as of Mar 25, the value is 4.92. This value exceeds the healthy maximum of 3. It has increased from 4.03 (Mar 24) to 4.92, marking an increase of 0.89.
For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.06. This value is within the healthy range. It has increased from 1.60 (Mar 24) to 2.06, marking an increase of 0.46.
For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 24) to 0.04, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Kingfa Science & Technology (India) Ltd as of March 10, 2026 is: ₹6,056.56

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 10, 2026, Kingfa Science & Technology (India) Ltd is Undervalued by 45.91% compared to the current share price ₹4,151.00

Intrinsic Value of Kingfa Science & Technology (India) Ltd as of March 10, 2026 is: ₹8,417.63

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 10, 2026, Kingfa Science & Technology (India) Ltd is Undervalued by 102.79% compared to the current share price ₹4,151.00

Last 5 Year EPS CAGR: 38.98%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has higher reserves (387.08 cr) compared to borrowings (41.00 cr), indicating strong financial stability. The company has shown consistent growth in sales (293.54 cr) and profit (67.38 cr) over the years.	The stock has a low average ROCE of 13.67%, which may not be favorable. The stock has a high average Working Capital Days of 51.50, which may not be favorable. The stock has a high average Cash Conversion Cycle of 63.67, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Kingfa Science & Technology (India) Ltd:
1. Net Profit Margin: 8.76%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 29% (Industry Average ROCE: 16.3%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 20.97% (Industry Average ROE: 12.17%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 23.97
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.31
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 33.5 (Industry average Stock P/E: 46.04)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.05
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Kingfa Science & Technology (India) Ltd. is a Public Limited Listed company incorporated on 10/11/1983 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L25209TN1983PLC010438 and registration number is 010438. Currently Company is involved in the business activities of Manufacture of other plastics products. Company's Total Operating Revenue is Rs. 1744.69 Cr. and Equity Capital is Rs. 12.11 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Plastics - Plastic & Plastic Products	Dhun Building, 3rd Floor, Chennai (Madras) Tamil Nadu 600002	Contact not found

Management
Name	Position Held
Mr. Bo Jingen	Managing Director
Mr. Doraiswami Balaji	Executive Director
Mr. Sun Yajie	Executive Director
Ms. Nilima Ramrao Shinde	Ind. Non-Executive Director
Mr. S K Subramanyan	Ind. Non-Executive Director
Mr. Ramachandran Sudhinder	Ind. Non-Executive Director

FAQ

What is the intrinsic value of Kingfa Science & Technology (India) Ltd?

Kingfa Science & Technology (India) Ltd's intrinsic value (as of 10 March 2026) is ₹8417.63 which is 102.79% higher the current market price of ₹4,151.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹5,625 Cr. market cap, FY2025-2026 high/low of ₹4,987/2,451, reserves of ₹1,281 Cr, and liabilities of ₹1,735 Cr.

What is the Market Cap of Kingfa Science & Technology (India) Ltd?

The Market Cap of Kingfa Science & Technology (India) Ltd is 5,625 Cr..

What is the current Stock Price of Kingfa Science & Technology (India) Ltd as on 10 March 2026?

The current stock price of Kingfa Science & Technology (India) Ltd as on 10 March 2026 is ₹4,151.

What is the High / Low of Kingfa Science & Technology (India) Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Kingfa Science & Technology (India) Ltd stocks is ₹4,987/2,451.

What is the Stock P/E of Kingfa Science & Technology (India) Ltd?

The Stock P/E of Kingfa Science & Technology (India) Ltd is 33.5.

What is the Book Value of Kingfa Science & Technology (India) Ltd?

The Book Value of Kingfa Science & Technology (India) Ltd is 955.

What is the Dividend Yield of Kingfa Science & Technology (India) Ltd?

The Dividend Yield of Kingfa Science & Technology (India) Ltd is 0.00 %.

What is the ROCE of Kingfa Science & Technology (India) Ltd?

The ROCE of Kingfa Science & Technology (India) Ltd is 30.6 %.

What is the ROE of Kingfa Science & Technology (India) Ltd?

The ROE of Kingfa Science & Technology (India) Ltd is 23.2 %.

What is the Face Value of Kingfa Science & Technology (India) Ltd?

The Face Value of Kingfa Science & Technology (India) Ltd is 10.0.